270 related articles for article (PubMed ID: 28415658)
1. Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.
Shen H; Che K; Cong L; Dong W; Zhang T; Liu Q; Du J
Oncotarget; 2017 May; 8(22):36812-36823. PubMed ID: 28415658
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
Xie W; Xie L; Song X
Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
Luo J; Shen L; Zheng D
Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract][Full Text] [Related]
6. The value of
Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.
Zhuang R; Li S; Li Q; Guo X; Shen F; Sun H; Liu T
PLoS One; 2017; 12(8):e0182562. PubMed ID: 28796802
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies.
Freidin MB; Freydina DV; Leung M; Montero Fernandez A; Nicholson AG; Lim E
Clin Chem; 2015 Oct; 61(10):1299-304. PubMed ID: 26272233
[TBL] [Abstract][Full Text] [Related]
9. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis.
Ye P; Cai P; Xie J; Wei Y
PLoS One; 2021; 16(3):e0248775. PubMed ID: 33770081
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.
Hao YX; Fu Q; Guo YY; Ye M; Zhao HX; Wang Q; Peng XM; Li QW; Wang RL; Xiao WH
Onco Targets Ther; 2017; 10():945-953. PubMed ID: 28243130
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.
Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J
Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus.
Altaf K; Xiong JJ; la Iglesia D; Hickey L; Kaul A
Br J Surg; 2017 Apr; 104(5):493-502. PubMed ID: 28295252
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
Yang X; Zhang K; Zhang C; Peng R; Sun C
BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.
Ren J; Kuang TH; Chen J; Yang JW; Liu YX
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):120-130. PubMed ID: 28121346
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis.
Passiglia F; Rizzo S; Di Maio M; Galvano A; Badalamenti G; Listì A; Gulotta L; Castiglia M; Fulfaro F; Bazan V; Russo A
Sci Rep; 2018 Sep; 8(1):13379. PubMed ID: 30190486
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis.
Yang B; Xiong WY; Hou HJ; Xu Q; Cai XL; Zeng TX; Ha XQ
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115208
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic predictive values of triggering receptor expressed on myeloid cell-1 expression in neonatal sepsis: A meta-analysis and systematic review.
Chang C; Gao Q; Deng G; Luo K; Zhu H
Front Pediatr; 2022; 10():929665. PubMed ID: 35935355
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Significance and Diagnostic Value of DLEC1 Hypermethylation in Lung Cancer: A Meta-analysis.
Li X; Mao W; Guo D; Xu H
J Nippon Med Sch; 2019; 86(2):62-69. PubMed ID: 31130567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]